Core Insights - The cannabis industry is experiencing growth, with many companies reporting strong quarterly earnings and expanding their operations, particularly in the U.S. [1][2] - Despite the potential for better trading, the sector remains volatile, presenting both opportunities and risks for investors [2][3] Company Highlights - **Tilray Brands, Inc.**: Recently launched a new premium cannabis strain, Platinum Pave, under the Broken Coast brand, showcasing its commitment to product innovation [4][5] - **Canopy Growth Corporation**: Appointed Luc Mongeau as the new CEO, expected to lead the company through its next growth phase, leveraging his cannabis and consumer packaged goods experience [6][8] - **Cronos Group Inc.**: Reported Q3 2024 earnings with net revenue of $34.3 million, an increase of $9.5 million from Q3 2023, while adjusted EBITDA improved by $9.2 million to $(6.0) million [9]

Core Insights - Canopy Growth has appointed Mr. Luc Mongeau as the new CEO, effective January 6, 2025, succeeding David Klein, who will transition to a special advisor role until August 31, 2025 [2][3][6] - Mr. Mongeau brings over 25 years of experience in the consumer packaged goods (CPG) sector, with a strong background in marketing, sales, supply chain operations, and mergers and acquisitions [4][6] - The company is focusing on asset-light expansion and achieving near-term profitability to capitalize on opportunities in the global cannabis market [2][3] Company Leadership Transition - Mr. Mongeau has been involved with Canopy Growth since early 2023 as a Board observer and became a Board member in February 2024, contributing to the company's strategic direction [2][3] - David Klein, the outgoing CEO, expressed confidence in Mr. Mongeau's leadership capabilities and will assist in the transition process [3][6] Company Positioning and Strategy - Canopy Growth is well-positioned for growth with a strong portfolio of well-known brands, a robust global medical cannabis business, and leading vaporizer technology from Storz & Bickel [3][8] - The company has established a comprehensive ecosystem to leverage opportunities in the U.S. THC market, including significant acquisitions such as approximately 77% of Lemurian, Inc. and 100% of Wana Brands [9] - Canopy Growth is committed to social equity, responsible use, and community reinvestment, aiming to enhance the understanding and acceptance of cannabis [10]

Canadian Gold Corp. Announces Non-Brokered Financing to Advance Phase 4 Exploration at TartanNovember 20, 2024 7:30 AM EST | Source: Canadian Gold Corp.Toronto, Ontario--(Newsfile Corp. - November 20, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") announces a non-brokered private placement offering of up to $750,000, by the issuance of flow-through common shares at a price of $0.19 per share.The proceeds raised from the issuance of flow-through common shares will be ...

Founded in 2017, Claybourne has built a reputation on originality and quality across California - one of the world's most competitive cannabis markets – helping redefine cannabis culture. Claybourne's Frosted Flyers Infused Pre-Rolls are the latest introduction from Canopy Growth into the rapidly growing and established infused segment in Canada. Since 2022, the pre-roll joint market in Canada has grown 94%1 – with infused pre-rolls now totalling 9.6% of the total recreational market2. "Claybourne Frosted F ...

Core Viewpoint - Canadian Gold Corp. has clarified that recent news releases mistakenly attributed to the company were actually related to other public companies, and the relevant wire services have been notified to correct these errors [1][2]. Company Updates - Canadian Gold Corp. has only released three significant updates in the fall of 2024: - On November 14, 2024, the company reported that Phase 3 drilling at the Tartan Mine returned multiple high-grade intercepts, extending the main zone to the west and indicating excellent potential for resource expansion [3]. - On October 16, 2024, initial results from Phase 3 drilling at the Tartan Mine showed high-grade mineralization extending to the west at 7.3 grams per tonne (gpt) gold over 7.0 meters, along with the discovery of a potential new zone [3]. - On September 25, 2024, surface samples from Hammond Reef South returned 11.6 gpt gold, indicating an expanding new gold discovery, and the company received a provincial funding grant to advance exploration [3]. Company Profile - Canadian Gold Corp. is a mineral exploration and development company based in Toronto, focused on expanding the high-grade gold resource at the Tartan Mine in Flin Flon, Manitoba. The Tartan Mine has a 2017 indicated mineral resource estimate of 240,000 ounces of gold at 6.32 grams per tonne and an inferred estimate of 37,000 ounces at 4.89 grams per tonne [4]. - The company also holds a 100% interest in exploration properties in Ontario and Quebec, adjacent to major gold mines and development projects, including the Canadian Malartic Mine, Hemlo Mine, and Hammond Reef Project [4]. - Robert McEwen, founder and CEO of Goldcorp, is a significant shareholder, owning 35% of the company [4].

Canopy Growth Corporation (NASDAQ:CGC) Q2 2025 Earnings Conference Call November 8, 2024 10:00 AM ET Company Participants Tyler Burns - Director of Investor Relations David Klein - Chief Executive Officer Judy Hong - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Bill Kirk - ROTH Capital Partners Michael Lavery - Piper Sandler Matt Bottomley - Canaccord Genuity Pablo Zuanic - Zuanic & Associates Operator Good morning. My name ...

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $1.80 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -150%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.37, delivering a surprise of -19.35%.Over the last four quarters, the company has ...

Revenue Performance - Storz & Bickel net revenue increased by 32% year-over-year to $16 million in Q2 FY2025, driven by strong growth in Germany and the U.S.[7] - Canada cannabis net revenue was $37 million in Q2 FY2025, an 8% decrease compared to Q2 FY2024, with medical cannabis increasing by 16% while adult-use cannabis declined by 24%[5][9] - International markets net revenue rose by 12% to $10 million in Q2 FY2025, with significant growth in Poland and Germany[6] - Canopy Growth reported net revenue of $62.99 million for the three months ended September 30, 2024, a decrease of 9.3% from $69.60 million in the same period last year[22] - Net revenue for the three months ended September 30, 2024, was $62,991, a decrease of 9% from $69,595 in the same period of 2023[25] - The Canada cannabis segment reported net revenue of $37,077 for the three months ended September 30, 2024, down from $40,266 in the same period of 2023[28] - The international markets cannabis segment revenue increased to $10,060 for the three months ended September 30, 2024, compared to $8,977 in the same period of 2023[28] - The Storz & Bickel segment generated revenue of $15,854 for the three months ended September 30, 2024, up from $11,991 in the same period of 2023[28] Financial Metrics - Consolidated gross margin improved by 100 basis points to 35% in Q2 FY2025, attributed to cost savings and a shift to higher-margin medical cannabis sales[2] - International cannabis gross margins increased by 1,700 basis points to 47% in Q2 FY2025, driven by a favorable sales mix[6] - The company's gross margin for the quarter was $21.84 million, representing a gross margin percentage of approximately 34.7%, down from $23.43 million in the prior year[22] - Gross margin for the three months ended September 30, 2024, was $21,838, representing a gross margin percentage of 35%, compared to 33% in the prior year[25] - Adjusted EBITDA loss was $6 million in Q2 FY2025, representing a 54% improvement year-over-year[2] - Adjusted EBITDA for the three months ended September 30, 2024, was $(5,507), compared to $(11,856) in the same period of 2023, indicating a reduction in losses[26] Cash Flow and Liquidity - Free cash flow outflow was $56 million in Q2 FY2025, a 16% improvement compared to Q2 FY2024, primarily due to reduced cash interest expenses[2] - Cash and short-term investments increased to $231 million at September 30, 2024, up from $195 million at June 30, 2024[2] - Cash and cash equivalents increased to $228.42 million from $170.30 million, indicating improved liquidity[20] - Cash and cash equivalents at the end of the period were $228,416, compared to $242,975 at the end of the previous year[24] - Net cash used in operating activities for continuing operations was $(53,852) for the three months ended September 30, 2024, down from $(66,393) in the same period of 2023[27] - Net cash provided by financing activities was $194,717 for the six months ended September 30, 2024, compared to $(407,298) in the same period of 2023[23] Operational Challenges - Operating loss from continuing operations was $45.94 million, compared to a loss of $7.01 million in the same quarter last year, indicating a significant increase in operating losses[22] - The company reported a net loss attributable to Canopy Growth Corporation of $128.29 million, compared to a net loss of $310.01 million in the same quarter last year[22] - Canopy Growth's accumulated deficit increased to $10.59 billion from $10.33 billion, highlighting ongoing financial challenges[21] Strategic Initiatives - Canopy USA completed the acquisition of Wana Brands, enhancing brand integration and market presence[8] - The company expects to launch an innovative infused pre-roll joint product in both adult-use and medical channels in the coming weeks[5] - The company aims to accelerate entry into the U.S. cannabis market, capitalizing on growth opportunities in the sector[13] - Expectations regarding future revenues, expenses, and cash needs are being closely monitored[16] - The company is focused on expanding production and manufacturing capabilities, with associated costs and timing being evaluated[16] - Future product offerings and anticipated gross margins are under consideration as part of strategic planning[16] - The company is assessing the impacts of regulatory changes on its operations and market participation[17] - There are expectations for the successful launch and scaling of cannabis-based products in legal jurisdictions[16] - The company is evaluating the potential success and costs associated with its acquisitions and strategic alliances[17] - The ongoing impact of cannabis legalization in various jurisdictions is being analyzed for its effects on market strategy[17] Shareholder Information - Canopy USA is expected to acquire all issued and outstanding Class D subordinate voting shares of Acreage at an exchange rate of 0.045 of a Company common share for each Floating Share held[15] - The anticipated investment in Canopy USA by the Huneeus 2017 Irrevocable Trust amounts to up to $20 million[15] - The company had 93,863,960 common shares issued and outstanding as of the reporting date[21]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38496 | --- | --- | |--------------------------------------------------------------------------------------------------|----- ...

3 Marijuana Stocks For 2024 Cannabis Investors Marijuana stock investors are keeping a close eye on the sector. The reason for this is all that is occurring in the sector at this time. We have companies preparing to report earnings on top of the politics surrounding the promises of the presidential election. Politics can greatly impact trading depending on the circumstances. For instance, when a politician speaks in favor of legal cannabis, it has the potential to create a rise in trading. Due to cannabis a ...